Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...

As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer ...

January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

As seen during the COVID-19 pandemic, bottlenecks can occur at various stages of the vaccine supply chain, including shortages of vaccine ingredients, packaging materials, and fill-and-finish ...

Today, Akribion Therapeutics, a German biotech company announced its €8 million ($8.2 million) seed round. Akribion Therapeutics is working on G-dase E, a programmable nuclease designed to selectively ...